.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Best Practices in Managing Indolent Systemic Mastocytosis (ISM)

EP. 1: Best Practices in Managing Indolent Systemic Mastocytosis (ISM)

February 19th 2025

EP. 2: Multidisciplinary Collaboration Is Vital for Timely, Definitive Diagnosis of Indolent Systemic Mastocytosis

February 26th 2025

Andrew Kuykendall, MD, discusses the importance of a nuanced, multidisciplinary approach to expedite the diagnosis of indolent systemic mastocytosis.

EP. 3: Beyond Serum Tryptase: Exploring Additional Testing Approaches for Indolent Systemic Mastocytosis

February 28th 2025

Tracy I. George, MD, discusses testing considerations in indolent systemic mastocytosis, including the role of serum tryptase and KIT D816V testing.

EP. 4: Avapritinib Leads a Charge of Novel Targeted Therapies for Indolent Systemic Mastocytosis

March 19th 2025

Tsewang Tashi, MD, discusses the efficacy and tolerability of targeted therapies like avapritinib for patients with indolent systemic mastocytosis.